Prostate Cancer - Results from #80

Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer. December 9, 2024

Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian Men. December 9, 2024

Artificial intelligence for detection of prostate cancer in biopsies during active surveillance. December 9, 2024

Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers. December 9, 2024

Immunome profiling in prostate cancer: a guide for clinicians. December 6, 2024

Post-prostatectomy Magnetic Resonance-guided Radiotherapy on a 1.5 Tesla Magnetic Resonance Integrated Linear Accelerator: Feasibility, Toxicity, and Preliminary Clinical Outcomes. December 6, 2024

Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study. December 6, 2024

Biochemical response to neoadjuvant androgen deprivation therapy before radiation therapy and the risk of death in patients with unfavorable-risk prostate cancer: A secondary analysis of a randomized clinical trial. December 6, 2024

Meeting Aerobic Physical Activity Guidelines and Associations With Physical Fitness in Men With Metastatic Prostate Cancer: Baseline Results of the Multicentre INTERVAL-GAP4 Trial. December 6, 2024

Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020. December 6, 2024

Irish Prostate Cancer Outcomes Research (IPCOR) registry: cohort profile. December 5, 2024

Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects. December 5, 2024

In-field prostate cancer recurrence following radical prostatectomy and salvage radiation. December 5, 2024

Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical Oncology. December 5, 2024

Transperineal 3D fusion imaging-guided targeted microwaves ablation for low to intermediate-risk prostate cancer: results of a phase I-II study. December 5, 2024

Impact of androgen deprivation therapy in patients with unfavorable intermediate-risk prostate cancer receiving brachytherapy-based dose-escalated radiation therapy. December 5, 2024

Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Radical Prostatectomy: The Prospective, Noninferiority, Nonrandomized HIFI Trial December 4, 2024

Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer December 4, 2024

First 2 Participants Dosed with Cu-64 SAR-bisPSMA in Co-PSMA Trial December 4, 2024

Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia. December 4, 2024

Page 5 of 1447